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Abstract
Opioid drug misuse and dependence are a social and public health problem in the United
States. Prescription opioid abuse and misuse have been associated with substantial
morbidity and mortality rates as well as social and economic costs. The purpose of this
project was to provide a systematic review of literature on the effectiveness of
medication-assisted therapy interventions in addressing the problem of prescription
opioid misuse in health care settings. The systematic review was completed through a
literature search conducted across five electronic databases. The review was guided by
the health belief model and eligible studies were rated using Johns Hopkins hierarchy of
evidence. Fifteen peer-reviewed journal articles published from 2011 met the inclusion
criteria and were reviewed in full. Of these, 14 were randomized controlled trials and 1
was a quasi-experimental study. The most commonly explored interventions were
psychosocial interventions in conjunction with medications for opioid addiction. Review
findings provided moderate evidence to support the effectiveness of psychosocial
interventions in conjunction with medications in the treatment of opioid dependence,
although the strength of the efficacy varied depending on the intervention provided. This
project may advance nursing field by promoting provision of care to opioid dependent
patients based on the best available evidence. Evidence-based care to patients with
prescription opioid dependence will positively impact social change by improving the
quality of life of patients, relieving caregivers of the burden of monitoring the addicted
patients and saving millions of dollars spent in the criminal justice and health care
systems.
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Section I: Overview of the Evidence-Based Project
Introduction
Opioid drug misuse and dependence is a major social and public health problem
in the United States (U.S) that has reached epidemic levels in the past few decades (Rudd
et al., 2016). Indeed, about 2 million U.S. adults abused or were addicted to prescription
opioids in the year 2014 (Hedden, 2015). Researchers have found that at least one in four
people who have received prescription opioids for pain not related to cancer become
addicted at some point (Boscarino et al., 2010). According to Crane (2013), at least 1,000
people are received daily in emergency departments as a result of abusing prescription
opioids. Addiction to opioid has been associated with substantial health risks including
the transmission of viral infections such as hepatitis B and C as well as Human
Immunodeficiency Virus (HIV) (Suryaprasad et al., 2014). Prospective studies have
shown that the risk of adverse health outcomes continues for many years after a diagnosis
suggesting that opioid dependence may be considered a chronic health condition (Edlund
et al., 2014; Hser, Evans, Grella, Ling, & Anglin, 2015).
Besides the adverse health effects associated with this form of substance misuse,
the use of opioids (including heroin and prescription opioids) led to the death of around
33,000 people in 2015, the highest mortality rate that has ever been reported (Center for
Disease Control and Prevention [CDC], 2017), suggesting that the mortality rate has been
increasing. Likewise, the National Institute on Drug Abuse (2017) reported that overdose
deaths related to prescription opioids increased three times between 2001 and 2015.
Almost 50% of all deaths related to opioid misuse involve a prescription opioid (Kolodny
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et al., 2015), highlighting the role of health care providers in promoting the health of
people misusing opioids.
Beyond the high mortality and morbidity rates, dependence on opioid inflicts
huge social and economic costs as a result of lost productivity, breakdown in
relationships, health care costs, and expenses related to law enforcement. It is estimated
that prescription opioid misuse and dependence carries a high economic burden for the
U.S, with the aggregate economic burden projected at $78.5 billion (Florence, Zhou, Luo,
& Xu, 2016). About 25% of this cost is borne by the public health care sector, substance
use therapy, and the costs incurred in the criminal justice system (Florence et al., 2016).
The findings shed light on the economic effect of opioid abuse and dependence; hence
highlighting the need to develop strategies aimed at reducing the social, economic, and
public health burden.
This project has implications for positive social change. In this project I have
provided a systematic and a critical review of the existing evidence on the effectiveness
of medication-assisted therapy interventions in reducing the problem of opioid misuse
and dependence in primary care setting. As a result, the study will ensure that nurse
practitioners stay at par with the best evidence on treatment of opioid dependence and
abuse. This will ascertain that they are able to provide evidence-based care to opioid
dependence patients leading to optimal patient outcomes, reduced health care costs, and
reduced mortality rate attributable to substance misuse.
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Problem Statement
Statistics on the prevalence of substance abuse indicate that substance use
disorder is a severe public health issue that requires evidence-based interventions. Public
health officials among other policymakers seem to have reached a consensus that the
opioid epidemic cannot be adequately resolved through the current punitive drug policies
(Substance Abuse and Mental Health Services Administration (SAMHSA) 2013;
Volkow, 2014). As a result, training programs aimed at impacting nurse practitioners
with the knowledge and appropriate skills to provide effective medication-assisted
therapies for patients on opioids are being offered in the U.S.
Nurse practitioners are ideally suited to carry out substance abuse interventions
because of their knowledge in the setting of health promotion (Nyamathi et al., 2011).
According to Lock et al. (2006), nurse-led interventions are effective in addressing
behavioral problems related to chronic alcohol intake among patients seeking care in the
primary care setting. However, information is lacking about the effectiveness of a nurseled intervention designed to reduce opioid abuse among adults receiving medicationassisted therapy in primary care settings. Therefore, the purpose of the capstone project
was to provide a systematic review of the literature on the effectiveness of medicationassisted therapy interventions in reducing the problem of opioid misuse and dependence
by adults seen in primary care settings.
Purpose Statement
The purpose of this capstone DNP project was to synthesize the best available
evidence on the effectiveness of medication-assisted therapy interventions in reducing the
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problem of opioid misuse and dependence by adults seen in primary care settings. A gap
exists in practice when nurse practitioners or other health care providers administer
interventions that are not supported by the best available evidence (Solomon, 2016), and
it was the purpose of this project to address such a gap. Thus, a systematic review is in
accord with the American Nurse Practitioner Association (ANA) position that as
providers offering care on the front lines of the opioid epidemic, registered nurse
practitioners are qualified and have a responsibility to play a leading role in monitoring
and managing patients struggling with this form of addiction (ANA, 2015). The identified
gap was addressed by conducting a systematic review of the existing empirical research
on the effectiveness of medication assisted therapy in dealing with the problem of
prescription opioid misuse and abuse by patients.
The population, intervention, comparison, and outcomes (PICO) question for this
project was: Does medication-assisted therapy interventions reduce the problem of opioid
dependence and misuse by adults seen in primary care settings? The population of
interest includes adult patients who are opiate addicts receiving care in primary settings,
the interventions and comparison include both pharmacotherapeutic and psychological
management of opioid addiction while the outcome measures of interest include abstinent
at follow up, withdrawal of signs and symptoms, adverse effects of treatment, and
completion of treatment.
The project has the potential to address the identified practice gap. It provided
scholarly information on best practices for the provision of medication-assisted therapies
by nurse practitioners to manage the problem of opioid misuse among patients seeking
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care at the practicum site. The evidence on best practices will empower practice nurse
practitioners in the mental health setting to make best decisions regarding patient care
based on EBP rather than rituals, traditions, and opinions by colleagues. The evidence
can also be used to develop educational programs aimed at raising nurse practitioner
knowledge and skills to offer effective medication-assisted therapies to opioid dependent
patients.
Nature of the Doctoral Project
There is a broad range of treatment options including psychosocial and
pharmacotherapeutic interventions that have been approved to treat opioid dependence.
There are currently three types of medications that have been approved for treatment of
opioid dependence, including naltrexone, buprenorphine, and methadone (Volkow et al.,
2014). Each of these drugs is to be used within a framework of social, medical, and
cognitive support which is part of the inclusive opioid dependence treatment approach
(Volkow et al., 2014). Nevertheless, there is a scarcity of reviews assessing the
effectiveness of medication-assisted therapy interventions by nurse practitioners in
reducing the problem of opioid misuse by adults seen in primary care (Brady, McCauley,
& Back, 2015). As a result, the purpose of the capstone project was to provide a
systematic review of literature on the effectiveness of medication-assisted therapy
interventions by nurse practitioners in reducing the problem of prescription opioid misuse
by adults seen in primary care settings.
To accomplish the purpose of the review, a literature search was carried out to
identify appropriate sources of evidence. Articles on the effectiveness of medication-
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assisted therapies were collected. Procedures followed in this review included defining
the research question, developing a literature search strategy, searching and identifying
relevant sources, extracting and analyzing data, and presenting and disseminating the
findings (Higgins & Green, 2011). The search for the literature focused on primary
studies as the main source of evidence. The search was conducted through five electronic
databases including EMBASE, CINAHL, PubMed, Cochrane Library, and PsyINFO.
Search terms related to psychosocial treatment, opioid dependence, addiction, medication
assisted therapy, and effectiveness were developed. The search was restricted to materials
available in full, published within the past decade and available in English language. The
title and abstracts of the articles were reviewed before downloading them and
determining their relevance. The findings will later be shared with the nurse practitioners
at my practicum setting and regional conferences held by mental health nurse
practitioners. An elaborate description of the sources of evidence is presented in Section
3.
Significance
Evidence-based practice (EBP) is crucial in the provision of quality care to
patients suffering from opioid dependence problems (Volkow et al., 2014). This capstone
project has the potential to strengthen EBP in the management of patients presenting with
opioid dependence in health care settings. The project was carried out through a
systematic review of the existing evidence on the effectiveness of medication assisted
interventions in reducing opioid dependence symptoms as well as promoting abstinence
in both the short and long-term. As a result, the capstone project provided the best
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available evidence on the management of opioid dependent patients thus empowering
nurse practitioners and other health care providers to make decisions regarding patient
care on the basis of the best available evidence rather than on traditions, rituals, and
opinions from colleagues. The literature reviewed has demonstrated the magnitude and
the burden posed by prescription opioid dependence on the health care system and
society in general (Edlund et al., 2014; Kolodny et al., 2015; Rudd et al., 2016); thus
demonstrating the importance of adopting the EBP to tackle the problem.
Implications for Social Change in Practice
As an advanced practice registered nurse (ANRP) who acts as an agent of change
for adoption of EBP, quality improvements efforts to promote the provision of care that is
consistent with the patient needs and supported by the best available evidence is essential
(Sperhac & Clinton, 2008). Nurse practitioners with a doctoral degree have a key
responsibility of shaping policies that could have an impact on nursing practice as well as
patient outcomes (Zaccagnini & White, 2015). The DNP capstone project was carried out
through a systematic review of literature approach, and the best available evidence was
synthesized to inform practice on the effectiveness of treatment strategies used to manage
opioid dependence. A review of literature highlighted a practice problem where health
care providers including nurse practitioners have poor prescription practices for the
management of opioid dependence (Solomon, 2016).
Health promotion is an essential role of a nurse with a doctoral degree (Sperhac &
Clinton, 2008). Evidence obtained from this capstone project could be used to advance
nursing practice by promoting safe and effective treatment methods for opioid
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dependence. The findings of the review can also promote practice change by providing
evidence-based models for management of patients suffering from opioid dependence.
Nurse practitioners ought to advocate for improved access of opioid dependence patients
to treatment programs providing evidence-based care. This will ensure that patients
benefit from the provision of patient-centered care that meets their short and long-term
needs.
The DNP project has the capacity to promote further positive social change in the
near future. Provision of care that is consistent with the patient needs and the best
available scientific evidence will positively impact social change by improving the
quality of life of opioid dependence patients. It will also result in a reduction in social
injustices that are as a result of opioid dependence while relieving family members and
care givers the burden of monitoring the patient addicted to prescription opioids.
Moreover, integration of the best available evidence will lead to a reduction in the
economic, social, and criminal justice system burden placed by opioid dependence.
Summary
In this section, prescription opioid dependence has been identified as a substantial
social and public health problem in the U.S. There are a broad range of treatment options
including psychosocial and pharmacotherapeutic interventions that have been approved
to treat opioid dependence. Nevertheless, there is a scarcity of reviews assessing the
effectiveness of medication-assisted therapy interventions by nurse practitioner in
reducing the problem of opioid misuse by adults seen in primary care. In addition,
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existing literature has identified poor prescription practices in the management of patients
suffering from opioid dependence.
The purpose of this capstone DNP project was to synthesize the best available
evidence on the effectiveness of medication-assisted therapy interventions in reducing the
problem of opioid misuse and dependence by adults seen in primary care settings. The
project will facilitate social change by promoting provision of evidence-based care
leading to improved quality of life for opioid dependence patients as well as reductions in
economic burden and contact with the criminal justice system. The next section will
provide a review of specific and general literature and a discussion of the theoretical
framework for this project.
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Section 2: Review of Scholarly Evidence
Introduction
The primary purpose of this scholarly project is to provide a systematic review of
literature on the effectiveness of medication-assisted therapy interventions in reducing the
problem of opioid dependence. Section 2 of the project scrutinizes general and specific
literature on the problem of opioid dependence. Specifically, the section discusses the
current guidelines for management of opioid dependence, the role of advanced practice
nurse practitioners in the management of opioid dependence and provides the theoretical
framework to guide the review.
Concepts, Models and Theories
Health Belief Model
The Becker’s (1974) health belief model (HBM) provided the theoretical
framework for the review. The HBM is a psychological model that was developed to
explain and predict health behaviors, especially regarding uptake of treatment and health
promotion services (Maiman & Becker, 1974). The model attempts to demystify and
predict human health related behaviors with a particular focus on their attitudes and
beliefs. It was initially developed in the 1950s by Hochbaum, Kegels and Rosenstock in
to explain why free screening programs provided by the U.S Public Health Services,
particularly for tuberculosis, were not effective. Since then, the model has been used to
examine a variety of short and long-lasting health behaviors such as sexual health risks
and substance misuse and dependence.
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The HBM is based on the premise that an individual will take a health related
action if he or she: feels that it is possible to avoid the negative health condition, perceive
themselves to be susceptible, believe that there would be serious repercussions, and
believe that there would be some benefits as a result of change (DiClemente, Salazar, &
Crosby, 2013). The model is composed of four major constructs including perceived
susceptibility, perceived severity, perceived benefits, and perceived barriers. These
concepts account individual’s readiness to change (Janz & Becker, 1984).
Additional concepts include cues to action which refers to readiness and stimulate
overt behavior and self-efficacy, which can be described as the confidence of an
individual in his or her capability to perform a certain action (Franckowiak & Glick,
2015). Having the confidence to taking action and integrating health behavior into the
daily life of the patient are essential in the management of chronic health conditions. The
efficacy of medical interventions is mostly dependent on the involvement of the patient in
self-care activities. Opioid addiction is by definition, a chronic health condition, and the
HBM has been used to study a variety of chronic health illnesses (Franckowiak & Glick,
2015).
Johns Hopkins Hierarchy of Evidence
The Johns Hopkins Nursing EBP model will be used to rate the strength of the
included evidence which may be judged by the type of the research design and quality of
methods. The model has five levels and has been selected because it is designed to meet
the needs of practicing nurse practitioners. Level I evidence refers to systematic reviews
or meta-analysis of experimental studies, experimental studies or randomized controlled
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trials (RCTs). Level II studies include quasiexperimental studies or systematic reviews of
quasi-experimental studies. Level III refers to nonexperimental studies as well as
systematic reviews with or without meta-analysis. The nonexperimental studies can be
quantitative surveys or qualitative studies or their systematic reviews with or without
meta-analysis. Level IV includes opinions of nationally recognised expert committees or
consensus panels reviewing scientific evidence. Lastly, Level V is based on experiential
evidence such as literature reviews, case reports, and quality improvement programs
(Dearholt & Dang, 2012).
Relevance to Nursing Practice
This DNP project is of relevance to nursing practice because it provided an update
on the effectiveness of medication-assisted interventions in improving outcomes in
patients living with opioid dependence. Nursing practice has a reputation for promoting
and enhancing the population health in the American society (Camicia et al., 2013).
Unsafe prescription practices for opioid addicts lead to medication errors and undermine
the reputation of nursing practice and, ultimately, the overall health care system (Ladd,
Sweeney, Guarino, & Hoyt, 2017). Reviewing evidence on medication-assisted therapies
can help registered nurse practitioners safely treat opioid addiction contributing to high
quality and safe care (Boscarino et al., 2010; Kolodny et al., 2015; Volkow et al., 2014).
A synthesis of best available practices can help address poor prescribing practices which
are not evidence-based leading to improved outcomes of patients with opioid dependence
problems.

13
The scope of practice for an APN allows for health assessment, diagnosis,
treatment, health education, prescriptive authority, and preventative health care among
more other responsibilities (Committee on the Robert Wood Johnson Foundation
Initiative on the Future of Nursing, at the Institute of Medicine., Robert Wood Johnson
Foundation., & Institute of Medicine, 2011). APNs have played a critical role in
addressing shortage of health providers in rural and marginalized areas (Tierney et al.,
2015). A 2010 report by the Institute of Medicine (IOM) emphasized that nurse
practitioners should be allowed to practice to the full extent of their training (IOM, 2011).
Nevertheless, states have depicted disparities in granting legal autonomy of doctorally
prepared nurse practitioners to practice and administer medications. Currently, 28 states
do not allow APNs to prescribe buprenorphine unless they are working in collaboration
with a physician who have a federal license to practice it (Pew Charitable Trusts, 2017).
Therefore, most APNs are prohibited from practicing to their full potential in the
provision of care to patients addicted to opioids despite evidence indicating that APNs
provide safe and effective quality care (Newhouse et al., 2011).
Advanced practice registered nurse’s narcotic prescriptive authority varies from
one state to another with some states granting nurse practitioners broader prescriptive
choice in comparison to others. For instance, Alabama and Florida have allowed APNs to
administer only a limited selection of controlled medications while 19 other states have
granted APNs permission to offer schedule II to IV drugs (Pew Charitable Trusts, 2017).
The variation in prescription authority is questionable considering that the level of
educational preparation and qualification for APNs is comparable across states and there
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are national accreditation programs to ensure quality and consistency. The DNP
candidate is a certified buprenorphine provider and has been approved for medication
assisted therapy for patients addicted to prescription opioids.
Existing Scholarship and Current State of Practice
The prevalence of prescription abuse and misuse has greatly increased in the past
two decades in the U.S. Currently, prescription opioids are the most frequently misused
drugs, second only to cannabis, with about 1.9 million people trying them on an annual
basis (Alderks, 2013). Data from the 2012 National Survey on Drug Use and Health point
out that there are around 12.5 million Americans who misused prescription opioids, a
substantial surge from 4.9 million reported in 1992 (Abuse, 2013). Cases of unintentional
prescription opioid overdose increased by four times and cases of emergency department
visits due to prescription opioid misuse increased by more than five times between 2000
and 2010 (CDC, 2017).
Some years before the 1990s, doctors were criticized for undertreating pain.
However, there was a paradigm shift in the 1990s and pain came to be known as the
“fifth vital sign” and general practitioners were encouraged to manage and address pain
aggressively (Brady et al., 2015; Calcaterra, Glanz, & Binswanger, 2013). Later in 2012,
the number of prescriptions written for opioids (259 million) was equivalent to the adult
population of the U.S (Brady et al., 2015). Pain management is now at the center of the
U.S. health care system with lawmakers and health practitioners attempting to minimize
the adverse effects of the increased access to prescription opioids at the same time
ensuring that pain is properly controlled.
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Prescription Practices
Opioids include both natural opiates and artificial congeners which are drugs that
generate morphine like effects. They act principally on three types of receptor in the
nervous system: delta, kappa, and mu (Tarter, Ammerman, & Ott, 2013). The mu
receptor is basically responsible for the analgesic and euphoric features of opioids and
attempts to generate an agent that produces analgesia without abuse potential have been
futile. Most of the opioid analgesics currently in use are full mu agonists (hydrocodone,
oxycodone, and morphine).
Buprenorphine is a partial mu agonist and an antagonist at the kappa receptor and
was approved by Food and Drug Administration (FDA) in 2002 for office-based
management of opioid dependence (Veilleux et al., 2010). The drug can be used during
maintenance and detoxification phases of opioid addiction. Considering that it is a partial
agonist, there is reduced risk of overdose and its use in the long-term has not been
associated with the development of severe withdrawal symptoms. Opioid antagonists
such as nalmefene, naltrexone, and naloxone bind to opioid receptors and can be
administered to prevent the effects of opioids (Kelly, Daley, & Douaihy, 2012).
Opioid encompass many specific agents available in a broad range of
preparations. Short-acting orally administered opioids including oxycodone, immediaterelease morphine, codeine, and hydromorphine usually have a quick onset of action (1060 minutes) and a short duration of action (2-4 hours) and are commonly used to manage
acute breakthrough pain (Zacharoff et al., 2010). Long-acting or extended release opioids
have a gentler onset of action (30-90 minutes) and a longer duration of action (4-72
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hours) and are commonly used in the management of chronic pain (Wilson, 2015). It is
recommended that providers should avoid administering more than one short-acting
opioid concomitantly unless there are documented medical reasons (Nuckols et al., 2014).
A combination of opioid and non-opioid analgesics is frequently used in the
management of patients with moderate pain. Using a combination product when dosage
intensification is needed raises the risks of adverse effects from the non-opioid coanalgesic even if increasing the opioid dosage was an appropriate action. In such
instances, the use of single agent formulations of opioid may be desirable (Kelly et al.,
2012; Nuckols et al., 2014).
As concerns about opioid abuse and misuse have increased, attempts focused on
developing abuse-deterrent and tamper-resistant opioid formulations have been made. A
4:1 formulation of buprenorphine and naloxone designed for sublingual administration,
marketed under the name Suboxone, is the most commonly used buprenorphine
formulation (Brady et al., 2015). Sublingual naloxone will not provoke withdrawal;
nevertheless, if Suboxone is administered intravenously, the naloxone will block the
euphorigenic effects of buprenorphine and might trigger withdrawal (Tarter et al., 2013).
Another deterrent technique is modifying the physical structure of tablets and
incorporating compounds that make it difficult to liquefy, concentrate or otherwise
transform the tablets. For instance, in 2014, FDA approved a new extended release
oxycodone/ naloxone formulation with abuse deterrent properties (Wilson, 2015). Such
preparations have been perceived as less vulnerable to abuse or misuse, though there is
still potential for misuse.
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The Office of National Drug Control Policy has put various strategies into place
to deter opioid misuse and abuse. The strategies include educating health care providers
as well as patients about the risks that are associated with abuse and misuse, promoting
the Prescription Drug Monitoring Program, and supporting proper disposal of
prescription drugs to avert diversion (Kuehn, 2014). On the other hand, best practice
recommendations by Executive Office of the President of the US (2011) acknowledged
the importance of balancing the benefits of opioids in pain management with the potential
risks conferred, especially by chronic pain. The guidelines advocate for the universal
application of risk mitigation strategies including mental health screening, conducting
urine screening tests, treatment agreements, and dosing guidelines.
Screening and Assessment
Considering that it is a challenge to predict who will misuse opioid medications,
universal risk assessment has been recommended. This means that all patients, including
those not chronically receiving opioid analgesics on a daily basis should be assessed for
the possibility of opioid abuse using validated tools prior to the commencement of opioid
therapy (Meltzer et al., 2011). Positive results from the assessment should be followed up
by a more rigorous assessment to collect further details. It is recommended that all
patients on opioid therapy should receive education on safe usage and disposal regardless
of their risk level (Barclay, Owens, & Blackhall, 2014).
There are a number of validated tools that can be used by health care providers to
weigh the risk of potential opioid misuse. It is essential that all patients undergo
screening before commencing opioid therapy. Validated screening measures include the
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Screener and Opioid Assessment for Patients with Pain and the Opioid Risk Tool (Passik,
Kirsh, & Casper, 2008). The two instruments are suitable for identification of patients at
risk of abuse or misuse before commencing opioid therapy. According to Butler et al.
(2010), positive screening alone is inadequate to rule out opioid therapy, and positive
results should be accompanied by a broader assessment such as clinical assessment and
urine drug screening to determine the safety and the risk benefit ratio of the treatment.
Treatment of Prescription Opioid use Disorders
Though disorders due to prescription opioid are around four times more common
compared to those of heroin use, therapy outcome research specific to prescription use
disorders is scanty, and the scope to which therapeutic interventions developed to address
the problem of heroin misuse can be effectively generalized to prescription opioid
dependence remains to a large extent ambiguous (Brady et al., 2015; Holmes, 2012). In
the absence of clear protocols to prescription opioid use disorders, most providers rely on
their clinical knowledge or experience regarding treatment options for opioid use
disorders.
Treatment for opioid use disorders typically involve medically supervised
withdrawal from the addicting drugs followed by maintenance with opioid substitution
therapies (Calcaterra et al., 2013). Opioid substitution or replacement therapy involves
administration of a longer acting opioid with less euphoric effects in an attempt to lessen
craving and reduce withdrawal symptoms. Opioid substitution therapy mostly involves
use of medication in the long-term, and in some cases, lifetime (Holmes, 2012). The two
most commonly used substitution therapies are buprenorphine and methadone. Around
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25% of patients with opioid use disorders have been administered with methadone
maintenance therapy (MMT), making it one of the most frequently administered
replacement therapy for opioid abuse and misuse disorders (Brady et al., 2015).
Effectiveness rate for MMT ranges from 20% to 70%, and the outcomes are dose
related, with individual variability in the effective dose (Mattick, Kimber, Breen, &
Davoli, 2008). Lower dosages (20-40mg/day) have been found to be effective at
subduing opioid withdrawal symptoms though they may not adequately reduce craving or
block the effects of other opioids. Maintenance dosages are generally in the range of 70120 mg/day, though some patients require more than 120 mg/day for optimal therapeutic
response (Mattick et al., 2008). The drug has been found to be effective in suppressing
withdrawal and blocking the effects impact of other opioids. There is evidence that MMT
improves treatment retention, reduces illicit opioid use, and is associated with reduced
criminal activities related to opioid misuse (Brady et al., 2015).
Buprenorphine was approved by FDA in 2002 as an office-based medication for
prescription opioid dependence, and by 2012, 51% of opioid treatment programs was
offering the drug (Wilson, 2015). The drug is a partial mu agonist; hence it is associated
with less euphoria and sedating effects compared to methadone. It has also been shown to
reduce withdrawal, hospital admission, morbidity, and mortality among individuals with
opioid use dependence (Bell et al., 2009). Similar to MMT, buprenorphine therapy can be
sustained for years (Rosenthal et al., 2016).
Lifetime or long-lasting opioid dependence therapy is not a preferable option for
some people with opioid dependence. In such a scenario, a substitution therapy (mostly
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Suboxone or buprenorphine) is steadily tapered and ultimately substituted with
naltrexone to promote continuous opioid abstinence (Tarter et al., 2013). Naltrexone is an
opioid antagonist that blocks the euphorigenic effects of opioids. While the efficacy of
naltrexone has been traditionally hampered by low adherence rates, injection and implant
options lately permitted by FDA have shown promising results (Kelly et al., 2012). The
medication can be administered with ease, is not addictive, and has not been found to
induce tolerance (Tarter et al., 2013). Nevertheless, considering that naltrexone
minimizes opioid tolerance, it can raise the risk of having an overdose among individuals
who return to illicit drug use. Mortality rates as a result of oral naltrexone are three to
seven times higher than those associated with MMT (Brady et al., 2015).
Local Background and Context
As providers offering frontline care to patients with opioid dependence, advanced
practice registered nurse practitioners are qualified and have a responsibility to play a
leading role in monitoring and managing patients. It is essential for nurse practitioners to
administer care that is backed by the best available evidence. Nurse practitioners at the
practicum site have limited knowledge of administering medication-assisted therapies
and are not confident in teaching patients about managing opioid dependence. The
practicum site is a mental health facility with a mission of empowering its clients and
families to cope with the challenges of various mental illnesses in an attempt to improve
the quality of their lives. The vision of the mental health center is to become a center of
excellence and a state leader in the field of mental health.
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The community mental health center serves adults aged 16 and above with
various mental challenges or symptoms of psychiatric illness. The mental health facility
also deals with the issue of opioid dependence and has care providers who administer
opioid medications. Collecting and analyzing data relating to the effectiveness of
interventions aimed at addressing the problem of opioid dependence will assist the nurse
practitioners at the practicum site by keeping them abreast of the changes in the field. The
evidence can also be used to improve their knowledge and skills in management of opioid
dependence thus reducing the impact of this problem on the individuals, families, society,
and the health care system.
Definitions of Terms
This subsection defines terms frequently used in this paper.
Advanced practice registered nurse: This is a nurse who has a master's, postmaster's certificate or doctoral of nursing educational level in nursing and had passed a
national licensure examination for nurse practitioners (ANA, 2010). They are also
referred to as advanced practice nurse practitioners (APNs), and both terms will be used
in this paper.
Opioid addiction/dependence: This is the inability of an individual to refrain from
using opioid drugs regardless of the detrimental problems and no benefits attributable to
their use (Edlund et al., 2014).
Evidence-Based practice: Refers to the integration of patient values, clinical
research, and best available evidence to make decisions regarding the provision of care to
patients (Sackett, 1997).
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Role of the DNP Student
I am an advanced practice nurse with background in primary care and mental
health and have worked for the current health center for more than a decade. I have taken
a course in opioid dependence management and I am certified to administer medications
and other interventions to manage this condition in an office-based setting. My
motivation for this project was to review evidence on the effectiveness of interventions
aimed at managing opioid dependence.
Opioids are commonly administered for management of severe pain and are
commonly abused by patients. I have been dealing with opioid dependent patients and my
optimism about this topic is that the evidence will improve nurse practitioners’
knowledge, skills, and confidence in the management of patients with this problem.
Having interacted with opioid dependent patients and administered medications might
have introduced bias in the review. To mitigate this bias, I followed the systematic and
consistent procedures in the process of searching, retrieving, and reviewing the evidence
presented in various studies before reaching a conclusion. I also did not have any
competing interest or further information that need to be disclosed prior to conducting
this review.
Summary
The prevalence of prescription abuse and misuse has skyrocketed in the past two
decades in the US. Currently, prescription opioids are the most frequently misused drugs,
second only to cannabis, with around 1.9 million people trying them on an annual basis.
Though disorders due to prescription opioid are four times more common compared to

23
those of heroin use, therapy outcome research specific to prescription use disorders is
limited. In the absence of clear protocols to prescription opioid use disorders, most
providers rely on their clinical knowledge regarding treatment options for opioid use
disorders. Therefore, there was a need to assess evidence from primary studies on the
effectiveness of medication assisted therapies in management of prescription opioid
dependence.
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Section 3: Collection and Analysis of Evidence
Introduction
The purpose of the capstone project was to provide a systematic review of
literature on the effectiveness of medication-assisted therapy interventions in reducing the
problem of prescription opioid misuse by adults seen in primary care settings. It is
important to have a clear understanding of the most effective and safe combination of
medication assisted therapy to effectively treat opioid dependence. Section 3 offers a
thorough description and justification of the methodology that will be used to carry out
the proposed systematic review.
Specifically, the section discusses the literature search techniques including the
databases, search engines, key words, and inclusion and exclusion criteria. This is
followed by a discussion of data analysis and quality assessment of the included journal
articles. Although there are other approaches that can be used to carry out a secondary
study, a systematic review approach was viewed as the most appropriate for the project of
this nature to collect and analyze evidence of effectiveness of medication assisted therapy
in treatment of opioid dependence.
Practice-Focused Question
Information is lacking about the effectiveness of nurse-led interventions aimed at
reducing the problem of opioid dependence in mental health settings. A gap exists in
practice when nurse practitioners or other health care providers administer interventions
that are not supported by the best available evidence. Therefore, the purpose of the
capstone project was to provide a systematic review of the literature on the effectiveness
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of medication-assisted therapy interventions in reducing the problem of opioid misuse
and dependence by adults seen in primary care settings. The question designed to guide
this project was: Do medication-assisted therapy interventions reduce the problem of
opioid dependence and misuse by adults seen in primary care settings? The gap in
practice was addressed by carrying out a systematic review of relevant evidence on the
effectiveness of interventions aimed at reducing the problem of opioid dependence.
Sources of Evidence
The DNP project was completed using the systematic review of literature method
of assessing the existing body of evidence on the effectiveness of medication assisted
therapies in the treatment of opioid dependence. The review was carried out based on a
revised version of the Cochrane systematic review handbook methodology. Steps
identified by the handbook include designing the research questions, developing the
literature search strategy, choosing and reviewing appropriate journal articles, gathering
and evaluating data, followed by presentation and analysis of the findings (Higgins &
Green, 2011). Data on the effectiveness of medication assisted interventions by nurse
practitioners in the treatment of opioid dependence was searched and critically assessed
while addressing the adequacy of the evidence and evaluating the outcomes.
Godfrey and Harrison (2010) asserted that a systematic review of literature
involves the analysis of the existing body of literature to establish the effectiveness of a
given practice. Reviewing evidence systematically provides a predetermined plan to
ensure consistency and minimize bias (Thomas, Ciliska, Dobbins, & Micucci, 2004),
making the findings of a review to be more reliable compared to those of individual
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studies. Nevertheless, the strength of the findings of a systematic review are good as that
of the included primary studies (White & Waddington, 2012), suggesting that if the
included studies contained flawed results; the conclusions reached on the review would
not be credible.
Published Outcomes and Research
The systematic review was carried out following a critical review of the existing
literature on the effectiveness of medication assisted therapy in treatment of opioid
dependence. The literature search was carried through five electronic databases including
PubMed, PsycINFO, EMBASE, CINAHL, and Cochrane Library. The electronic
databases were selected because they contain peer-reviewed journal articles. According
to Sampson et al. (2009), peer review process is an important step in validating the
quality of research as a result of through the rigorous steps involved in the process. A
supplementary search for grey literature was carried out through Google Scholar and
organizational websites that offer services or carry out research involving people living
with prescription opioid dependence.
Search terms related to psychosocial treatment, opioid dependence, addiction,
medication assisted therapy, and effectiveness were used. The search terms were
broadened to identify appropriate journal articles. The searches were restricted to all
fields including keywords, abstracts, and titles and will be restricted to studies involving
human participants. A computer-assisted search through the various databases was
carried out using the same search terms. This process was supplemented by performing a
hand search to check the relevance of the included data. This is in line with Armstrong et
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al.’s (2005) affirmations that hand searching is suitable tool in the search for evidence
because it promotes the inclusive analysis of journal issues which may be in form of
conference proceedings or case studies not published in major electronic databases.
Boolean operators (AND, OR or NOT) were used in the literature search to
combine search terms in an attempt to build a more focused search. Another advanced
literature search technique that was used is truncation (e.g effect* to retrieve articles that
included the word effect, effectiveness, and effective) to broaden the search process.
Spelling variations and alternative words were also be taken into consideration so as to
build a comprehensive search. The use of advanced search techniques has been supported
by Ecker and Skelly (2010) who claimed that it makes it allows reviewers to identify
appropriate journal articles with ease.
Other major literature search techniques employed to carry out the review
included citation searching and footnote chasing. Citation searching is a powerful
technique that focuses on identifying articles citing known journal articles published
previously (Kear & Colbert-Lewis, 2011). The technique was used to locate all articles
that were the original sources on the research topic. A closely related literature search
technique is footnote chasing and was used to locate relevant journal articles by carefully
searching the bibliography of the identified papers. According to Tubré et al. (2011),
footnote chasing tends to have a high precision considering that other researchers had
reviewed the content of the materials and found them relevant to the current topic.
Citation searching and footnote chasing literature search techniques were used to
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supplement the literature search and possibly led to identification of up-to-date articles
missed during the electronic database search.
Evidence Generated for the Doctoral Project
The literature search was to journal articles published from January 2011 to 2018.
This is in accord with Booth, Sutton, and Papaioannou’s (2016) recommendation that
reviewers should strive to include a realistic timeframe to act as a benchmark for deciding
which studies should be included in a review. The search was restricted to studies
available in English language and those involving human beings as participants. The
participants should be adult patients receiving treatment of prescription opioid
dependence from nurse practitioner or other health care providers. Outcomes of interest
include opioid use, changes in symptoms, treatment retention, and attendance to
counseling attendance.
Eligible materials include articles evaluating the effectiveness of medication
assisted therapy for treatment of prescription opioid dependence. In an event that an
article presented a secondary analysis of data from an eligible study, the original report
will be tracked and included in the review. Study designs that were considered included
quasi-experimental, randomized controlled trials, case control, and cohort studies. Only
articles available in full were included.
The exclusion criteria included journal articles published before 2010, those
involving participants receiving treatment for opioid dependence not as a result of
prescription, and those published in any other language apart from English. The review
also excluded non-empirical articles including editorials, literature reviews, and
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commentaries. In addition, studies that failed to include sufficient control groups or
whose study design did not allow for determination of the effectiveness of medication
assisted therapies in combination with psychological treatment will be ineligible.
Procedures
Plonsky and Gass (2011) asserted that clinical trials are crucial resources that
have an impact on decisions relating to management of chronic health conditions. DixonWoods et al. (2007) added that assessing the quality of the research techniques used to
conduct research is an essential strategy in the identification of the most robust evidence
in health care. The claim has been reinforced by arguments (Thomas & Harden 2008)
that the characteristic of the techniques used in conducting a primary study can indicate
the level of validity and reliability of the findings of the study. Moreover, assessing the
methods used to conduct research is essential because the differences in the quality of the
methodology used can have a profound effect on the conclusions reached about the
effectiveness of a particular intervention.
Following a scrutiny of several reviews, Moher et al. (2009) found that
randomized controlled trials that failed to offer essential details such as how the blinding
of participants was done tended to report biased positive results compared to those that
had outlined the procedures clearly. Assessing the quality of primary studies has attracted
much debate in the recent past, with a number of tools being developed to assess the
credibility of the included studies.
The John Hopkins Evidence-based Practice model was used to evaluate the
quality of the included evidence. The model has placed primary research into three levels
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including level I (randomized controlled trials), level II (quasiexperimental) and level III
which includes observational studies such as cohort studies and case series (Dearholt &
Dang, 2012). Evidence from these study designs is rated on a three-point scale of high
quality (Grade A), good quality (Grade B), and low quality (Grade C). High quality
evidence comes from studies that had involved a representative and sufficient sample
size, had adequate control, and produced findings that can be generalized. Good quality
evidence comes from studies that had an adequate sample size, some control, and
reasonably consistent results. Grade C evidence comes from studies that did not have
representative and sufficient sample size for generalizability of the findings (Johns
Hopkins Medicine, 2017) (See Appendix A).
Protection of Human Subjects
The review did not involve human participants directly hence it can be considered
to be of low risk considering that ethical issues such as confidentiality and informed
consent that arises with the collection of primary data will be minimal. As highlighted in
the previous sub-section, the DNP candidate collected data regarding the effectiveness of
medication-assisted therapies in the management of opioid dependence. Therefore, no
human participants were required to take part or a direct medical record will be used to
identify participants, hence no need to seek informed consent. Nevertheless, to ensure
that the review complies with all ethical principles guiding research and fulfill the
University’s DNP project, the project leader sought Institutional Review Board at Walden
University, following the guidelines in the systematic review manual for approval.
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Analysis and Synthesis
The data were extracted by the reviewer together with a colleague. Any
differences that emerged as a result of the differences in the extracted information were
solved through a discussion. This is in line with Cronin, Ryan, and Coughlan’s (2008)
recommendation that the data collection process should not be affected by any form of
researcher prejudice. To accomplish this, Ramdhani, Ramdhani, and Amin (2014)
recommended collecting data with the help of a colleague so as to not only reduce bias,
but also save time on the data collection exercise.
The review involved screening of the titles and abstracts of journal articles to
determine if an article satisfied the inclusion criteria. The project leader extracted the data
while her colleague cross-checked the data extraction forms for consistency,
comprehensiveness, and accuracy. Characteristics of the study including authors, study
design, participants, intervention, and main findings were collected to provide an
overview of the included studies. This was followed by a critical analysis of the included
materials to determine if there were confounding factors that may have led to biased
results or conclusions.
The evidence from eligible studies was rated using Johns Hopkins hierarchy of
evidence. The hierarchy of evidence has three levels including level I for RCTs, level II
for quasi-experimental and level III for observational studies (Johns Hopkins Medicine,
2017). Word processing software was used to store the references in a systematic
manner. This is a valuable approach in processing and generating a list of reference list of
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journals which allows duplicate references to be identified and deleted with ease (Cronin,
Ryan, & Coughlan, 2008).
The process for developing a systematic literature review begins with the
development of a practice-focused question, acquisition of evidence, appraisal of the
evidence, determining applicability, putting into practice, and assessing the outcomes
(Godfrey & Harrison, 2010). The collection of the literature was completed through the
search conducted through the electronic databases.
Summary
A clear understanding of the most effective interventions in the management of
prescription opioid abuse and misuse is critical. As a result, the purpose of the capstone
project was to provide a systematic review of literature on the effectiveness of
medication-assisted therapy interventions in reducing the problem of prescription opioid
misuse by adults seen in primary care settings. This section provided a discussion of the
methodologies that was used to carry out the study. In summary, an exhaustive search
was carried out across five major databases and data was collected, analyzed, and
critiqued using the Johns Hopkins hierarchy of evidence model. Section 4 presents an
evaluation of the findings of the systematic review.
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Section 4: Findings and Recommendations
Prescription opioid abuse and dependence is a major social and public health
problem that has been escalating at a high rate in the U.S leading to high rates of
overdose deaths and an increased number of patients seeking help for opioid dependence.
The current problem of opioid dependence cannot be solved through the current punitive
drug policies (Volkow, 2014). Nurse practitioners are ideally suited to carry out
substance abuse interventions because of their knowledge to promote health. Therefore,
the purpose of the capstone project was to provide a systematic review of the literature on
the effectiveness of medication-assisted therapy interventions in reducing the problem of
opioid misuse and dependence by adults seen in primary care settings.
The sources of evidence were mostly peer-reviewed journals, both from nursing
and other healthcare related disciplines. The review was carried out based on a revised
version of the Cochrane Systematic Review Handbook methodology. Steps identified by
the handbook include designing the research questions, developing the literature search
strategy, choosing and reviewing appropriate journal articles, gathering and evaluating
data, followed by presentation and analysis of the findings (Higgins & Green, 2011).
Data on the effectiveness of medication-assisted interventions by nurse practitioners in
the treatment of opioid dependence was searched and critically assessed while addressing
the adequacy of the evidence and evaluating the outcomes.
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Literature Search Results
The literature search was carried out across CINAHL, Google Scholar, PubMed,
and Cochrane library and it led to the identification of 912 studies, which after removing
duplicates, 832 articles were left for the review. The titles and abstracts of the articles
were reviewed to establish if they had satisfied the inclusion criteria. In total, 104 articles
were reviewed in full, and 15 articles were identified as eligible for inclusion in this
review. 14 were randomized controlled trials while only one study could be classified as
quasi-experimental (see Figure 1).

912 articles identified

After removing duplicates,
832 studies were obtained

After reading title and
abstract 104 studies
obtained

Only 15 studies were
included
Figure 1. Selection process of the studies.

80 articles were excluded

728 articles were
excluded
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The Johns Hopkins Nursing EBP model was used to rate the strength of the included
evidence based on the type of the research design and quality of methods (Appendix B).
The most commonly explored interventions were psychosocial interventions in
conjunction with medications for opioid addiction. The most commonly investigated
psychosocial intervention was cognitive behavioral therapy while the most frequently
administered medication was methadone. The results of this review found moderate
evidence to support the effectiveness of psychosocial interventions in conjunction with
medications in the treatment of opioid dependence, although the strength of the efficacy
varied from one study to another depending on the intervention provided.
Study Outcomes and Limitations of Included Studies
Most of the studies (n=15) indicated improvements in one or more of the outcome
measures. Three of the included studies (Chen et al., 2013; Kidorf et al., 2013; Petry,
Alessi, & Ledgerwood, 2012), focused on contingency management of opioid addiction,
which is a type of treatment that provides rewards to people who demonstrate the desired
behaviors such as reduced opioid misuse.
Chen et al. (2013) sought to determine whether contingency management
intervention implemented by the methadone maintenance treatment (MMT) clinic staff
would improve adherence to treatment and reduce addiction to opioid misuse. A total of
126 patients were randomly assigned to receive prize-based contingency management
while 120 were placed in the MMT group which was the usual care. All the participants
had to provide urine samples twice a week for a period of 12 weeks, and those in the
contingency management group won awards after delivering morphine negative urine
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samples and attend MMT. The retention rate and negative urine testing was 14.2% (p =
0.010) and 10.7% (p < 0.001) higher in the contingency management group compared to
the usual care group, respectively. In comparison to the usual treatment groups, those in
the contingency group attended more statistically significant more days of therapy (p <
0.01). The findings indicate that contingency management is an effective approach to
reducing opioid misuse and encouraging attendance to treatment sessions for people
addicted to opioids.
Consistent findings were reported by Kidorf et al. (2013) randomized controlled
trial that found participants in the contingency management group attended more
psychiatric sessions each month (M = 5.71 vs. 2.44, p < .001) in comparison to the
control group. The study involved 125 patients who were involved in the contingency
management group and the control group. Participants in the two groups received the
same schedule and magnitude of treatment which included daily methadone
administration. Those in the contingency group received $25 per week upon attending all
the sessions. Although the participants in the contingency group demonstrated greater
attendance at psychiatric sessions, no significant differences were noted between the two
groups in terms of substance use outcomes. Contrary to the findings of Chen et al. (2013),
these researchers failed to find any evidence to support the effectiveness of contingency
management in reducing substance use.
Petry, Alessi, and Ledgerwood (2012) assessed the effectiveness of contingency
management delivered by clinicians in a randomized controlled trial. There were 16
healthcare providers who provided care to 130 patients placed in the contingency

37
management or the usual clinic care (MMT). Urine and breath samples were collected
biweekly for a period of 12 weeks. Those in the contingency group had an opportunity to
win prices of up to $100 for submitting urine samples negative of opioids and alcohol.
Similar to Chen et al. (2013), those in the contingency management group remained in
the study longer (9.5 weeks versus 6.7 weeks), abstained from opioid misuse for a longer
duration (4.7 weeks versus 1.7 weeks), and submitted a higher percentage of negative
urine samples (67.7% versus 29.4%) compared to those in methadone maintenance
therapy alone. Nevertheless, the findings of the study ought to be interpreted in the
context of its limitations. The differential rates of follow-up may have biased the longterm outcome measures (most of the participants followed were in the intervention
group). At the same time, the study was carried out by clinicians at methadone clinics and
involved methadone dependent patients hence the findings may not be generalizable to
other clinician and patient population.
Cognitive-behavioral Therapy (CBT)
Of the 19 studies included in this review, there were seven that assessed the
effectiveness of CBT in combination with medication-assisted therapy. Kouimtsidis,
Reynolds, Coulton, and Drummond (2012) multicenter randomized controlled trial
evaluated the effectiveness of CBT in combination with MMT in the UK context.
Participants were randomly assigned to the usual care group (MMT, n=31) or MMT plus
CBT group (intervention, n=29). In addition to receiving the usual care, those in the
intervention group took part in weekly individual CBT sessions for a period of six
months. Although participants in the intervention group demonstrated statistically
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significant improvements in positive expectancies of treatment, the findings showed no
substantial between group mean differences in terms of abstinence rates, MMT
compliance, psychological symptoms, and severity of psychosocial problems.
Likewise, Moore et al. (2013) pilot study assessed the efficacy and feasibility of
MMT as usual care (n=18) in combination with Therapeutic Interactive Voice Response
(IVR) (n=18) for patients addicted to illegal opioids. IVR is a CBT-based therapeutic
approach system that incorporates coping skills, goal setting, and self-monitoring.
Consistent with the findings of Kouimtsidis et al. (2012), the trial did not find statistically
significant differences between the groups in terms of substance use, study retention,
MMT satisfaction, coping skills, or urinalysis-verified opioid abstinence. Those in the
intervention group, however, were more likely to report opioid abstinence on the days the
used the recovery line (p=0.01) in comparison to the days they did not. Participants were
not followed-up, thus, making it hard to determine the impact of the intervention in the
long-term. Besides, a small sample size was used hence the findings may not be
generalizable to other settings.
Pan et al. (2015) sought to determine whether CBT in conjunction with MMT
therapy can reduce opiate misuse. The trial involved 240 opiate-dependent patients
seeking care in community-based clinics and were randomly placed into the MMT groups
(n=120) or the MMT plus CBT group (n=120). Compared to the standard care group, the
CBR group had a higher percentage of opiate-negative urine tests at the end of three
months (59% vs. 69%, p<0.05) and 63% vs. 73%, p<0.05) at the end of six months. The
findings are contrary to those reported by Kouimtsidis et al. (2012) and Moore et al.
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(2013) who did not find statistically significant improvements. Nevertheless, there was
no follow-up in Pan et al. (2015) study thus it cannot be determined if the positive aspects
persist in the long-term.
Amini-Lari et al. (2017) evaluated the effectiveness of CBT in the treatment of
opiate dependence in conjunction with MMT. A total of 118 participants who were
regular users of opiates were randomly selected and placed in the usual care group (n =
59) or the CBT plus MMT group (n = 59). CBT significantly reduced opiate use (p <
0.01, d = 0.89) and the severity of opioid dependence (p < 0.01, d = 0.64) after one month
of treatment. The findings indicate that the addition of the CBT component improves
MMT effectiveness in reducing opiate dependence.
Salehi and Alizadeh (2018) assessed the effectiveness of CBT and MMT in
preventing opiate dependence based on cognitive-behavioral relapse prevention model.
The study involved a total of 50 patients with opiate dependence and was randomly
assigned into two groups. At the end of the six-month study period, 84% and 48% of the
participants in the intervention and control groups showed abstinence from opioid misuse
(P < 0.001). CBT was also associated with substantial improvement in self-efficacy of the
participants in the intervention group.
There were two included trials which explored the effectiveness of CBT in
combination with buprenorphine treatment. The first one was by Fiellin et al. (2013) trial
that sought to establish the effect of CBT in combination with naloxone/buprenorphine
treatment for opioid dependence. The study involved 141 opioid-dependent patients in a
primary care clinic. There were no statistically significant differences between the two
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groups in terms of reductions in opioid misuse, although the two groups had a statistically
significant pretest-posttest reduction in opioid misuse (p <0.001). It should be noted that
the structured physician management usual care was more frequently administered than
the standard practice for clinicians managing opioid dependence; thus, the care provided
by clinicians could have created treatment outcomes that made it difficult to demonstrate
the effectiveness of CBT.
A similar study by Moore et al. (2012) explored the effect of two counseling
sessions with two medication dispensing methods in patients receiving buprenorphine in
primary care settings. In a three-month duration, opiate-dependent patients were assigned
to physician management weekly buprenorphine therapy (n=28) and while 27 participants
were placed in the buprenorphine and CBT group (intervention). There were no
statistically significant differences between the two groups with regards to opioid
abstinence, treatment retention, and participant satisfaction. Among those in the
intervention group, CBT session attendance was positively associated with negative
opioid urine (p <0.05).
General Supportive Counseling
Gu et al. (2013) sought to determine the effectiveness of adding psychosocial
intervention to the usual clinic care in decreasing attrition and addressing non-attendance
by the first-time newly admitted MMT users (n=288). Social workers provided
counseling sessions based on the behavioral maintenance theory. Family members were
involved, and misconceptions about MMT were addressed. In comparison to the control
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group, the intervention group had a statistically significant lower risk of attrition and
attended more days of MMT treatment (p <0.001) during the study period.
A similar study by Weiss and Rao (2017) evaluated the effectiveness of opioid
dependence counseling sessions in conjunction with buprenorphine (n=653). The trial
failed to demonstrate any benefits of adding counseling to buprenorphine/naloxone
medical management. Only around 7% of the patients achieved successful abstinence or
near abstinence from opioids within an eight-week period of follow-up. Long-term
follow-up findings were more encouraging with patients on opioid agonist treatment
more likely to experience better outcomes. Although the study did not find sufficient
evidence to support general counseling, this does not mean that patients should not be
counseled. Some may do well with just medical management while others might do better
upon receiving additional counseling.
Other Psychosocial Interventions
Brigham et al. (2014) assessed the effectiveness of a community reinforcement
approach and family training in the context of buprenorphine treatment (n=104). The 14week trial involved opioid-dependent adults enrolled in a residential buprenorphine
detoxification program and concerned significant others (CSO) to improve treatment and
treatment retention. The intervention led to moderate but non-significant improvements
in treatment retention compared to the control group. When CSO was a family member,
there was a significant impact on treatment retention (p <0.01). Community
reinforcement and family training is a promising intervention, but there is a need for
further studies to confirm the findings. The study suffered from a series of limitations
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such as small sample sizes, lack of power to determine the effectiveness of the
intervention, and limited generalizability of the findings.
The use of telephonic support systems to provide counseling in conjunction with
buprenorphine care was assessed in Ruetsch, Tkacz, McPherson and Cacciola (2012)
trial. A total of 1,426 patients were randomized to standard care (buprenorphine) or
buprenorphine in conjunction with general counseling delivered through telephone calls.
The study found that participants who accepted at least three intervention calls were more
adherent to medication than those in the usual care group after one year (64.4% vs.
56.1%, p <0.25). Patients who were compliant with treatment reported statistically
significant lower scores of all the addiction severity index scores suggesting lower
severity on addiction-related problems.
Zhang et al. (2016) sought to explore the effects of standard care (MMT) in
comparison to MMT in conjunction with psycho-education on opioid use, treatment
adherence, and methadone use. The study involved a total of 492 MMT clients who had
tested positive for morphine prior to intervention. The educational intervention focused
on increasing methadone treatment literacy, promoting adherence to MMT, and goal
setting. In the course of the intervention, positive urine morphine rates decreased by
22.3% from 49.3% (p <0.001). In addition, the average daily methadone dosage increased
to 72.6 mg from 63.0 (p <0.001) while the average number of days the participants were
able to access MMT increased by 4.5% from 69.4% over a period of three months. The
findings show that psycho-education in conjunction with MMT has the potential to
promote adherence to treatment, reduce opioid misuse, and improve patient outcomes.

43
Nevertheless, the use of urine morphine test results was the main indicator of
effectiveness, and participants could avoid using opioids prior to the urine tests thus
generating a spurious intervention effect. The absence of a comparison group makes it
hard to confidently determine the effectiveness of the intervention provided.
Recommendations
The primary focus of this review was on providing a systematic review of the
literature on the efficacy of medication-assisted therapies in the management of the
opioid dependence problems. The incremental benefit of adding psychosocial
interventions to medically assisted treatments varied across studies with the psychosocial
interventions provided. The findings of this review can be used to improve practice in the
management of opioid dependence problem. The importance of developing best practices
regarding management of opioid dependence is crucial. With the increasing number of
U.S citizens struggling with opioid addiction and with the enactment of the Affordable
Care Act, it is likely that the demand for management of opioid dependence will continue
increasing.
It is important to ascertain that physicians and advanced nurse practitioners
understand the best outcomes that may be achieved once they manage opioid dependence
through the various medication-assisted therapies. It is also critical that advanced nurse
practitioners with authority to manage opioid dependence problems should be
knowledgeable about various pharmacological approaches as well as psychosocial
interventions and be able to use them in conjunction. A clear understanding of safety and
efficacy is needed for them to manage opioid dependence problems successfully.
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Appropriate use of medication and psychosocial interventions will also have implications
for social change. It will enable people with opioid addiction problems to seek therapy
and reduce the social injustices that are associated with addiction. In the future, the
findings of this review can help reduce the criminal justice and health-care burdens
incurred due to prescription opioid dependence.
Strengths and Limitations
A strength of this review is that it contributes to the existing body of knowledge
by critically reviewing evidence from various primary studies about the effectiveness of
medication-assisted therapies in addressing the problem of opioid dependence. In
addition, most of the studies included in this review were randomized controlled trials
which are considered as gold standard in research; hence the findings are less susceptible
to bias due to randomization of the participants into the intervention or control groups.
The review was affected by several limitations. The first one is that the literature
search was limited to only those materials published in English language. The second
limitation is that the researcher did not carry a formal assessment of the risk of bias as
required in systematic reviews and meta-analysis, although risk of bias is likely to be low
considering that the researcher collected data together with a colleague. Implications for
future research is determining the specific forms of psychosocial interventions that are
most effective when used alone or in combination with medications depending on the
patient populations and treatment settings.
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Section 5: Dissemination Plan
Dissemination of scholarly findings marks the conclusion of doctoral nursing
projects; it is essential to share the findings of an EBP project with other practitioners to
improve healthcare practice (Zaccagnini & White, 2015). The outcomes of a project
should be shared with the academic community, project stakeholders, and other
practitioners working in similar settings. Dissemination of the scholarly findings may be
of benefit to other practitioners in similar settings. There are several approaches to
disseminating project findings that can be used to disseminate the findings of this review.
The first approach that will be used to disseminate the findings of this review is
through the publication of the results. The DNP candidate will seek publication of the
findings in a nursing journal that is that deals with addiction problems and other mental
health issues. An abstract or a summary of the project in a peer-reviewed journal such as
the Journal of Addictions Nursing would be an ideal approach. Publication in this journal
would allow the results to reach nurse practitioners and other practitioners dealing with
patients addicted to opioids.
The second approach that can be employed to disseminate the findings is an oral
presentation. This can be in the form of oral presentation or lectures in a given context
(Edwards, 2015). I plan to create a professional poster and share the findings of the
review with my colleagues in the workplace. I am also considering attending a regional
conference on addiction problems, and this would provide an ideal platform to share the
information regarding the findings of this project. Annual conference within my state can

46
provide an ideal opportunity to attract a large group of healthcare professionals providing
care to patients who are opioid dependent.
The crucial audience for the output of this project includes the project team at my
workplace with whom I discussed the ideas within this project. Individuals that I
discussed this project with included the nursing manager, site mentors, and nurse
practitioners working at the hospital. Implementation of any practice change was beyond
the scope of this review, but the findings could promote a reevaluation of the current
practice to ensure that patients addicted to opioids benefit from the medication provided
as well as appropriate cognitive and behavioral interventions.
Analysis of Self
The complexity of the contemporary healthcare environment requires nurse
practitioners to be up to date with information and be in a position to address the gap
between research evidence and practice. Based on the knowledge and skills that I have
developed in the course of carrying out this review and my DNP course, I feel adequately
prepared to perform my roles as an advanced nurse practitioner. In this subsection, I will
provide an analysis of self as a practitioner, scholar, and project manager while drawing a
connection between my experience in this project and long-term professional goals.
As a Nurse Practitioner
Translation of research findings into practice in the increasingly complex
healthcare environment is the hallmark of scholarly nursing practice (Zaccagnini &
White, 2015). Even though I was aware of the importance of evidence-based practice
when commencing my DNP project, carrying out this review made me reflect on my
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practice as an advanced nurse practitioner certified to manage patients with opioid
addiction problems. I have been able to appreciate the role of behavioral and cognitive
therapies in the management of opioid dependence problems and I will now be able to
make the best clinical decisions based on the best available evidence.
I have developed expertise throughout the DNP course and project that will help
me function as a nurse leader. I aspire to become a nurse leader and promote adoption of
best practices in the field of mental health. According to American Association of
Colleges of Nursing (AACN) (2006), doctorally prepared nurse practitioners are expected
to provide leadership for the adoption and implementation of evidence-based practices
for the management of the various conditions. Throughout the DNP course and project, I
have developed in various aspects of an advanced nurse practitioner; I have become
equipped with knowledge and skills to review, appraise, and make use of research
evidence to improve nursing practice.
As a Scholar
AACN (2018) defines nursing scholarship as activities that characteristically
advance the teaching, research, and practice of nursing through rigorous processes. By
carrying out the systematic review of the effectiveness of the various medication-assisted
therapies in the management of opioid dependence, I have been able to contribute to
scholarship in the field of addiction and substance misuse. I intend to further contribute to
nursing scholarship through the distribution of the findings of this DNP project as
outlined in the dissemination plan.
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Carrying out this research has also improved my writing skills which are critical
for an advanced nurse practitioner. I encountered several revisions, and this contributed
to improvements in my writing skills. My writing skills have improved, and I have been
able to acquire the status of a scholarly doctoral writer. I have also developed my critical
analysis skills which I could have described as basic at the beginning of my doctoral
project. The research involved reading research materials from different sources,
critically appraising the information, and synthesizing the findings to reach meaningful
conclusions.
As a Project Developer
A doctorally prepared nurse is expected to be in a position to identify and address
a healthcare problem in their setting. As a nurse practitioner, I have encountered
numerous patients addicted to opioids initially prescribed to manage non-cancer pain.
Thousands of people are dying due to opioid dependence highlighting the need for
effective interventions to reduce the addiction and mortality associated with opioid
dependence. As a result, I carried out this literature review with an intention of
identifying best practices in the management of opioid dependence.
The process of completing this doctoral project was challenging but provided me
with an opportunity to learn through experience. Carrying out a literature search and
synthesizing the information took more time than I anticipated. In essence, time
management was an issue, and I found myself lagging behind the project schedule. Upon
reflecting on this challenge, I realized that I had allocated inadequate time to the various
phases of this review. I had to revise my schedule to allow more time for various
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activities such as literature search and analysis. I also had to work towards improving my
personal discipline in following a set schedule by avoiding unnecessary interruptions and
having specific, measurable, and realistic goals. The knowledge and the time
management skills that I developed by carrying out this project have improved my
confidence as a manager, and I will now be able to take part in identifying and
developing evidence-based solutions to the current problems facing nursing practice.
Summary
Prescription opioid misuse and dependence has risen to epidemic proportions in
the U.S. The problem has been associated with substantial morbidity and mortality rates
besides inflicting huge social and economic costs as a result of lost productivity, health
care costs, and expenses related to criminal justice. The purpose of this project was to
provide a systematic review of literature on the effectiveness of medication-assisted
therapy interventions in addressing the problem of prescription opioid misuse in health
care settings. The most commonly explored interventions in the included studies were
psychosocial interventions in conjunction with medications for opioid addiction. The
most commonly investigated psychosocial intervention was cognitive behavioral therapy
while the most frequently administered medication was methadone. The results of this
review found moderate evidence to support the effectiveness of psychosocial
interventions in conjunction with medications in the treatment of opioid dependence.
It is important that advanced nurse practitioners with authority to manage opioid
dependence problems are knowledgeable about various pharmacological approaches as
well as psychosocial interventions and be able to use them in conjunction. A clear
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understanding of safety and efficacy is needed for them to manage opioid dependence
problems successfully. Appropriate use of medication and psychosocial interventions will
also have implications for social change. It will enable people with opioid addiction
problems to seek therapy and reduce the social injustices that are associated with
addiction. In the future, the findings of this review can help reduce the criminal justice
and health-care burdens incurred due to prescription opioid dependence.
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Appendix A: Systematic Review Matrix
Citatio
n

Country

Objective

Research Design
(include tools) and
Sample Size

Key Findings

Strengths and
limitations

AminiLari et
al.
(2017)

Iran

To evaluate the
effectiveness of
CBT in the
treatment of
regular opiate
use on a stable
methadone dose

Multicenter RCT
Valid and reliable
tool (Severity of
Dependence Scale)
118 patients who
were regular opiate
users were selected
Control 59,
Intervention 59

CBT significantly
reduced opiate use (z =
3.73, P = 0.01, d =
0.89) and the severity
of opiate dependence
(z = 7.36, P = 0.01, d =
0.64) after four weeks
of treatment

Strengths
No participant attrition
Limitation
Only one follow-up
95% of the participants
were men, hence findings
largely applies to men
Participants not blinded

Brigha
m et al.
(2014)

USA

To test the
efficacy of a new
psychosocial
intervention
(CRAFT-T) in
comparison to
usual treatment

RCT
52 adult participants
with prescription
opioid dependence

CRAFT-T led to
moderate effect on
treatment retention (p
= 0.058,). There were
large and statistically
significant effects on
treatment retention
when family members
were involved (p <
0.01).

Chen et
al.
(2013)

China

To assess the
impact of
contingency
management
intervention
implemented by
MMT clinic on
treatment
attendance and
drug abstinence.

RCT, 126
participants
received
contingency
management (CM),
while 120 received
usual treatment
(UT),
Zung Self-rating
Depression Scale
was used

Strengths
Randomization reduces
bias in the selection
process
No missing data on the
primary outcome measure
Limitations
Small sample size: lack of
generalizability, lack of
power to evaluate
therapist effects and to
fully evaluate the effects
of CSO relationship type,
and possibly distorted
estimates of effect sizes
The retention rate and
Strengths
negative urine testing
Randomization eliminates
rate were 14.2%
bias in the selection
(P=0.010) and 10.7%
process
(P<0.001) higher in the Sample selected from
CM group compared to different part of the city
hence findings are
usual care group,
respectively. In
representative
comparison to UT, CM Limitations
group missed an
Lower frequency of urine
average of 7.3 fewer
monitoring (twice a week
(p=0.008) and were
while past studies
1.91 (95% CI: 1.53monitored more than 3
2.39) times more likely times a week)
to submit a negative
urine sample.

Level
of
Eviden
ce
Level 1,
Quality
B

Level 1,
Quality
B

Level 1,
Quality
A

66
Fiellin
et al.
(2013)

USA

To assess the
effects of CBT
on outcomes in
primary care,
office-based
buprenorphine/n
aloxone
treatment of
opioid
dependence

24-week
randomized clinical
trial
141 opioiddependent patients
Patients were
randomized to UT
or UT + CBT

Gu et
al.
(2013)

China

To investigate
the relative
efficacy of
adding a psychosocial
intervention to
the usual care in
decreasing
attrition and nonattendance
among first-time
newly admitted
MMT users

RCT, 142
participants in
intervention group,
146 in the usual
care group

Kidorf
et al.
(2013)

USA

To assess the
effectiveness of
contingency
management to
enhance the use
of psychiatric
services located
and integrated
within a
communitybased MMT
program.

RCT, 125 Opioiddependent
outpatients took
part
Participants met
DSM-IV-R criteria
for psychiatric
diagnosis
Self-Report
Measure of
Medication
Adherence was
used

The 2 treatments had
similar effectiveness in
reduction of selfreported frequency of
opioid use, from 5.3
days per week (95%
confidence interval,
5.1–5.5) at baseline to
0.4 (95% confidence
interval, 0.1–0.6) for
the second half of
maintenance (P<.001
for the comparisons of
induction and
maintenance with
baseline), with no
differences between
the 2 groups (P=.96) or
between the treatments
over time (P=.44).
Compared to the usual
care group, those in the
intervention group
showed significantly
lower risk of attrition
(HR =0.55, 95 % CI
0.39-0.80), lower
estimated probability
of attrition after one
year (0.35 vs. 0.55)

No selection bias due to
randomization
An appropriate sample
size hence findings
generalizability
Limitations
Eligibility criteria could
have excluded people
who were less likely to
experience significant
improvements

Level 1,
Quality
B

Strengths
A relatively large sample
used
Randomization reduces
selection bias
Limitations
Study only carried out in
one city
No blinding of
participants or healthcare
providers

Level 1,
Quality
B

Participants in the
intervention group
attended more overall
psychiatric sessions at
the first month ((M =
7.53 vs. 3.97, p < .001,
month 2 (M = 6.31 vs.
2.81, p < .001, and
month 3 (M = 5.71 vs.
2.44, p < .001). Similar
rates of drug-positive
urine samples. No
differences in study

Project was associated
with significant
improvements in
attendance of the
treatment sessions
Limitation
Concerns regarding
feasibility due to high
cost of attendance
incentives ($165)
Study did not control for
prescription practices,
which may have

Level 1,
B

67

Kouimt
sidis et
al.
(2012)

UK

To investigate
the effectiveness
and costeffectiveness of
CBT in MMT
for opioid
dependent
patients

RCT, 60 patients

Moore
et al.
(2012)

USA

RCT
Intervention group,
28 UT + CBT
Control, 27 UT
Self-reported opioid
abstinence
questionnaire used

Moore
et al.
(2013)

USA

To investigate
the impact of
two counseling
intensities in
patients
receiving
buprenorphine in
primary care
To assess the
feasibility,
acceptability,
and efficacy of
interactive voice
response for
patients
receiving MMT

Pan et
al.,
2015

China

To test whether
CBT in
conjunction with
MMT improves
treatment
retention and
decreases opiate
use

RCT, 36 patients,
UT or recovery line
+ UT

RCT, 240 opiate
dependent patients,
CBT=120 patients,
standard 120
Addiction Severity
Index (ASI) scale
used

retention were
observed.

introduced unknown error
variance

No substantial between
groups mean
differences in terms of
abstinence rates, MMT
compliance,
psychological
symptoms, and
severity of
psychosocial
problems.
Analyses adjusting for
baseline characteristics
showed no significant
differences between
groups on retention or
drug use based on selfreport or urines.

Strength
Randomization
Limitations
Small sample size

Strength
Randomization reducing
selection bias
Limitation
Small sample size lacking
statistical power
Lack of follow-up after
intervention
Patients were more
Randomization of
participants
likely to report
abstinence for opioids
Limitations
and cocaine on days
Small sample size
they used the Recovery There were marginally
Line (p = .01) than
significant differences on
those they did not.
baseline variables such as
gender

Compared to control
group, intervention
group had a higher
proportion of opiatenegative urine tests
At both 12 and 26
weeks, CBT group
exhibited more

Strengths
Random selection of
participants
Large sample size
Limitations
Frequency of urine
collection may not have

Level 1,
C

Level I,
B

Level I,
C

Level I,
B

68

Petry,
Alessi,
&
Ledger
wood
(2012)

USA

To assess the
effectiveness of
contingency
management
(CM) in treating
opioid
dependence

RCT, 130 patients
randomized to CM
or standard care

Ruetsch
et al.
(2012)

USA

To assess the
impact of
telephonic
patient support
program on
opioid dependent
patients

RCT, 1426 opioid
dependent patients
completed the
Addiction Severity
Index (ASI) pre and
post-intervention

Salehi
&
Alizade
h
(2018)

Iran

To assess the
effectiveness of
CBT on relapse
prevention in
opioid dependent
people

RCT, 50 opioid
users
Placed into UT
(control) or UT+
CBT (intervention)

decreases in ASI
employment scores at
week 26 and more
decrease in the PSS
total score at week 12
and week 26.
CM group remained
longer in the study
(9.5 ± 3.6 versus 6.7 ±
5.0 weeks), and
submitted a higher
proportion of negative
samples (57.7% ±
40.0% versus 29.4% ±
33.3%) than those
assigned to standard
care
Compared to patients
who were noncompliant with BUP,
compliant patients
reported significantly
lower scores on all 7 of
the ASI composite
scores, indicating
lower severity on
addiction-related
problems.
At the end of 6
months, 84% and 48%
of the subjects from
the intervention and
control groups showed
abstinence from drug
use, respectively. The
findings indicated a
significant difference
regarding self-efficacy
between the groups (P
< 0.001).

been sufficient to detect
drug use

Strengths
Randomization
Limitation
Differential rates of
follow-up completion
likely biased long-term
outcome
Provision of cash gift
prices raises costs hence
concerns regarding
sustainability
Strength
Huge sample size
Generalizability
Limitations
Missing follow-up data

Level I,
B

Randomization
Limitations
Small sample size
92% of participants were
males, limited diversity

Level I,
B

Level I,
B

69
Weiss
& Rao
(2017)

USA

To determine the
impact of adding
opioid drug
counseling to
buprenorphinenaloxone plus
medical
management on
opioid use
outcomes

Two-phase RCT,
653 participants age
>18.
Composite
International
Diagnostic
Interview to assess
substance misuse

Vast majority of
prescription opioid
users failed to achieve
success after tapering
off bup-nx, whereas
about half of the
patients achieved
successful outcomes
while maintained on
bup-nx.

Strength
Long follow-up period,
42 months
National, multi-site study
sample
Limitation
Trial failed to
demonstrate any benefits
of adding counseling to
UT

Level I,
B

Zhang
et al (
2017)

China

To investigation
effects of
psychoeducation
on treatment
compliance,
methadone dose,
and heroin use
among MMT
clients

Quasi experimental,
492 MMT clients
who tested positive
for urine morphine

During the
intervention, urine
morphine positive
rates reduced to 27 %
from 49.3 %
previously; p < 0.001

Huge sample size
Limitation
No comparison group
Spurious intervention
effect

Level
II, B
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